1don MSN
Commercially viable biomanufacturing: Designer yeast turns sugar into lucrative chemical 3-HP
Using a tiny, acid-tolerant yeast, scientists have demonstrated a cost-effective way to make disposable diapers, ...
Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
A research team presents an overview of recent advances in the microbial biosynthesis of L-tryptophan (L-Trp) and its ...
5d
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...
Optimising RSV sample handling and laboratory workflows to support faster, more efficient clinical trial delivery.
Explore how multi-angle light scattering enhances biosimilar analysis by delivering accurate molecular weight and size ...
AZoLifeSciences on MSN
Synthetic biology and metabolic engineering drive microbial L-tryptophan biomanufacturing
This review synthesizes progress in pathway optimization, regulatory rewiring, and microbial cell factory design that has ...
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an upda ...
Discover how much a pet wellness plan could save you.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback